Enrolling Minors in COVID-19 Vaccine Trials
- PMID: 33334920
- PMCID: PMC7919110
- DOI: 10.1542/peds.2020-040717
Enrolling Minors in COVID-19 Vaccine Trials
Abstract
It is widely agreed that an effective response to the coronavirus disease 2019 pandemic needs to include a vaccine that is safe and effective for minors. However, many current vaccine trials have no plans for when to enroll minors. Others have recently proposed enrolling minors as young as 12 years old. This lack of a systematic approach raises 2 concerns. Waiting too long to enroll minors could unjustly deny minors and their families the benefits of a vaccine and has the potential to delay an effective response to the pandemic by a year or longer. At the same time, enrolling minors too soon runs the risk of exposing them to excessive risks. With these concerns in mind, in the present article, we propose recommendations for when and how to enroll minors in vaccine trials for the coronavirus disease 2019.
Copyright © 2021 by the American Academy of Pediatrics.
Conflict of interest statement
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
References
-
- Aubrey A. Will kids get a COVID-19 vaccine? Pfizer to expand trial to ages 12 and up. National Public Radio. October 13, 2020. Available at: https://www.npr.org/sections/health-shots/2020/10/13/923248377/will-kids.... Accessed October 24, 2020
-
- Gill D; Ethics Working Group of the Confederation of European Specialists in Paediatrics . Ethical principles and operational guidelines for good clinical practice in paediatric research. Recommendations of the Ethics Working Group of the Confederation of European Specialists in Paediatrics (CESP). Eur J Pediatr. 2004;163(2):53–57 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical